Newsfile Corp
05 Oct 2026, 03:13 UTC · 1h ago
ROSEN, TRUSTED TRIAL COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
Impact · against what's priced in
The announcement of a lead plaintiff deadline for an existing class action lawsuit against Unicycive Therapeutics is not a material catalyst. The lawsuit itself is already a known factor, and a procedural reminder for investor counsel does not change the company's fundamental valuation.
- UNCY−0.10
No priced-in read yet





